Publications by authors named "Amit A Lugade"

Claim this Profile
M
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Kunle Odunsi, Feng Qian, Amit A Lugade, Han Yu, Melissa A Geller

Sci Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells Aryl Hydrocarbon Receptor Activation.
Adaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, Han Yu, Tao Liu, Amit A Lugade

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD14 HLA-DR monocytic cells as a biomarker for epithelial ovarian cancer progression.
Ashley E Stenzel, Scott I Abrams, Janine M Joseph, Ellen L Goode, Joseph D Tario, Amit A Lugade

Am J Reprod Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.
Takemasa Tsuji, Kevin H Eng, Junko Matsuzaki, Sebastiano Battaglia, J Brian Szender, Amit A Lugade

Oncotarget· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Gynecologic Cancer: Current Applications and Future Directions.
Sarah Lynam, Amit A Lugade, Kunle Odunsi

Clin Obstet Gynecol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung Inflammation.
Mehrab Nasirikenari, Amit A Lugade, Sriram Neelamegham, Zhongwei Gao, Kelley W Moremen

Front Immunol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.
A J Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, Cheryl Eppolito, Anthony Miliotto, Amit A Lugade

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
Song Liu, Junko Matsuzaki, Lei Wei, Takemasa Tsuji, Sebastiano Battaglia, Amit A Lugade

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.
Thinle Chodon, Amit A Lugade, Sebastiano Battaglia, Kunle Odunsi

Hematol Oncol Clin North Am· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature of tumour rejection antigens in ovarian cancer.
Muzamil Y Want, Amit A Lugade, Sebastiano Battaglia, Kunle Odunsi

Immunology· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.
Adaobi Amobi, Feng Qian, Amit A Lugade, Kunle Odunsi

Adv Exp Med Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial.
Venkata K Pokuri, Garin M Tomaszewski, Sihem Ait-Oudhia, Adrienne Groman, Nikhil I Khushalani, Amit A Lugade

Am J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.
J Brian Szender, Antonios Papanicolau-Sengos, Kevin H Eng, Anthony J Miliotto, Amit A Lugade

Gynecol Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.
Suresh Gopi Kalathil, Amit Anand Lugade, Renuka Iyer, Austin Miller, Yasmin Thanavala

Oncoimmunology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 and Foxp3 T cell reduction correlates with survival of HCC patients after sorafenib therapy.
Suresh Gopi Kalathil, Amit Anand Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala

JCI Insight· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
Suresh Gopi Kalathil, Amit Anand Lugade, Vandana Pradhan, Austin Miller, Ganapathi Iyer Parameswaran

Am J Respir Crit Care Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.
Amit A Lugade, Paul N Bogner, Thomas H Thatcher, Patricia J Sime, Richard P Phipps

J Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.
Amit A Lugade, Dhruba J Bharali, Vandana Pradhan, Galina Elkin, Shaker A Mousa

Nanomedicine· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
Amit A Lugade, Suresh Kalathil, Austin Miller, Renuka Iyer, Yasmin Thanavala

Oncoimmunology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.
Suresh Kalathil, Amit A Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala

Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
Mark B Jones, Mehrab Nasirikenari, Amit A Lugade, Yasmin Thanavala, Joseph T Y Lau

J Biol Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine model of chronic respiratory inflammation.
Amit A Lugade, Paul N Bogner, Yasmin Thanavala

Adv Exp Med Biol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Yasmin Thanavala, Amit A Lugade

Adv Otorhinolaryngol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae.
Amit A Lugade, R Robert Vethanayagam, Mehrab Nasirikenari, Paul N Bogner, Brahm H Segal

Am J Respir Cell Mol Biol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling.
Amit A Lugade, Anna Bianchi-Smiraglia, Vandana Pradhan, Galina Elkin, Timothy F Murphy

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis